Holen Sie sich die Stockscreener-App
0.8169
3.13%
-0.0264
Handel nachbörslich:
.83
0.0131
+1.60%
Schlusskurs vom Vortag:
$0.8433
Offen:
$0.83
24-Stunden-Volumen:
333.96K
Relative Volume:
0.35
Marktkapitalisierung:
$87.51M
Einnahmen:
$33.03M
Nettoeinkommen (Verlust:
$-44.63M
KGV:
-1.9482
EPS:
-0.4193
Netto-Cashflow:
$-36.18M
1W Leistung:
-4.79%
1M Leistung:
+3.22%
6M Leistung:
-47.30%
1J Leistung:
-65.31%
1-Tages-Spanne:
$0.8092
$0.8435
1-Wochen-Bereich:
$0.8092
$0.8809
52-Wochen-Spanne:
$0.6434
$2.4694
Maxcyte Inc Stock (MXCT) Company Profile
Firmenname
Maxcyte Inc
Sektor
Branche
Telefon
301-517-5556
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
0.8169 | 90.34M | 33.03M | -44.63M | -36.18M | -0.4193 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | Eingeleitet | Stephens | Overweight |
| 2023-11-29 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | BTIG Research | Buy |
| 2021-08-24 | Eingeleitet | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | Stephens | Overweight |
| 2021-08-24 | Eingeleitet | Stifel | Buy |
| 2021-08-24 | Eingeleitet | Wedbush | Outperform |
| 2021-08-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
MSN Money - MSN
MaxCyte (MXCT) price target decreased by 11.67% to 4.33 - MSN
BTIG Downgrades MaxCyte (MXCT) - MSN
MaxCyte (MXCT) price target decreased by 14.88% to 4.90 - MSN
SEC Form DEFA14A filed by MaxCyte Inc. - Quantisnow
[ARS] MAXCYTE, INC. SEC Filing - Stock Titan
Directors and auditor on ballot at MaxCyte (NASDAQ: MXCT) 2026 meeting - Stock Titan
MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026 - The Manila Times
MaxCyte schedules May 12 earnings release, 4:30 p.m. call - Stock Titan
MaxCyte (MXCT) Stock: Short-Term Trend (Technical Strength) 2026-04-27Insider Info - newser.com
MaxCyte announces 34% workforce reduction to cut costs - MSN
MaxCyte sees Q4 core revenue between $6.6M and $6.7M - MSN
MaxCyte, Inc. (MXCT) reports Q4 loss, misses revenue estimates - MSN
MXCT (MaxCyte Inc.) shares fall 4.09 percent despite Q4 2025 EPS beat and double-digit year over year revenue decline.Investment Signal Network - Cổng thông tin điện tử tỉnh Tây Ninh
MXCT (MaxCyte Inc.) shares climb more than four percent after Q4 2025 EPS tops consensus analyst expectations. - Xã Thanh Hà
MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Form S-8Securities to be offered to employees in employee benefit plans - ADVFN
Wall Street Zen Downgrades MaxCyte (NASDAQ:MXCT) to Sell - MarketBeat
MaxCyte (MXCT) CFO receives 187,500 restricted stock units in equity grant - Stock Titan
Earnings Call Summary | MaxCyte(MXCT.US) Q4 2025 Earnings Conference - 富途牛牛
FOMO Trade: Is MaxCyte Inc stock risky to hold nowWeekly Profit Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Rally Mode: Can MaxCyte Inc sustain its profitability2026 Breakouts & Growth Focused Stock Reports - baoquankhu1.vn
Fed Watch: Will MaxCyte Inc benefit from rising consumer demand2026 Rallies & Weekly Sector Rotation Insights - baoquankhu1.vn
MaxCyte (MXCT) CFO awarded 375,000 employee stock options at $0.6762 - Stock Titan
MAXCYTE (MXCT) CFO Parmeet Ahuja named reporting insider in Form 3 - Stock Titan
Mirabella exit leaves MaxCyte (NASDAQ: MXCT) ownership at 0% after Jan 5, 2026 - Stock Titan
Activity Recap: Is MaxCyte Inc showing insider buying2026 WrapUp & Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Final Week: Is MaxCyte Inc being accumulated by smart money - baoquankhu1.vn
Aug Rallies: Is MaxCyte Inc a momentum stock2026 Intraday Action & Technical Pattern Alert System - baoquankhu1.vn
Pullback Watch: Is MaxCyte Inc forming a breakout patternWall Street Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 earnings call transcript - MSN
Quarterly Earnings: Is MaxCyte Inc stock a value trap2026 Key Highlights & Growth Focused Entry Reports - baoquankhu1.vn
Is MaxCyte (MXCT) Stock Good for Passive Investors | Price at $0.74, Down 1.31%Community Breakout Alerts - newser.com
MXCT PE Ratio & Valuation, Is MXCT Overvalued - Intellectia AI
Finanzdaten der Maxcyte Inc-Aktie (MXCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):